Clinuvel Pharmaceuticals Limited Profit Margin

As of the most recent data (December 2025), CUV.AX shows a profit margin of 38.11%. That compares with 37.28% in the prior-year period — up 2.2% year over year. That is above the Healthcare sector average of 9.48%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CUV.AX's profit margin is now 38.11% (was 37.28%) — a 2.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Clinuvel Pharmaceuticals Limited is outperforming or lagging.

The Healthcare sector average profit margin is about 9.48%. Clinuvel Pharmaceuticals Limited is at 38.11%, which is higher that average. That is roughly 301.9% above the sector mean. Use the comparison chart on this page to see how CUV.AX stacks up against individual peers as well.

That compares with 37.28% in the prior-year period — up 2.2% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Clinuvel Pharmaceuticals Limited with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Clinuvel Pharmaceuticals Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 38.11%) with ownership activity and broader fundamentals.